innovothera

Sightera

Sightera develops an artificial intelligence platform for drug discovery to design small-molecule therapies for oncology and fibrosis patients.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Sightera Biosciences

Sightera Biosciences develops AI-designed small molecule drugs for pharmaceutical partners and patients with therapy-resistant cancer and fibrosis.

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

Gain Therapeutics

This biotechnology company develops allosteric small molecule therapies for patients with neurodegenerative diseases and rare genetic disorders using an artificial intelligence drug discovery platform.

Alevin Therapeutics

This biotechnology company develops small molecule integrin inhibitors to treat patients with life-threatening fibrotic diseases, including lung, liver and kidney conditions.

Soley Therapeutics

This company develops drug discovery software and novel medicines for patients using artificial intelligence and cellular stress-sensing technology to identify new therapeutic candidates.

Deepcure

This company develops small molecule therapies for pharmaceutical organisations to treat inflammatory and autoimmune diseases using artificial intelligence and automated discovery tools.